J A Marrinan

2.3k total citations
17 papers, 1.9k citations indexed

About

J A Marrinan is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, J A Marrinan has authored 17 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in J A Marrinan's work include Antifungal resistance and susceptibility (8 papers), Peptidase Inhibition and Analysis (3 papers) and Enzyme Production and Characterization (3 papers). J A Marrinan is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Peptidase Inhibition and Analysis (3 papers) and Enzyme Production and Characterization (3 papers). J A Marrinan collaborates with scholars based in United States, Sweden and Japan. J A Marrinan's co-authors include Cameron Douglas, Martha Kurtz, Janet C. Onishi, Susan Bock, Elzbieta Radziejewska, Sarah Dreikorn, George K. Abruzzo, I. Brent Heath, Myra B. Kurtz and Ken Bartizal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Journal of Bacteriology.

In The Last Decade

J A Marrinan

17 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J A Marrinan United States 14 925 636 546 507 293 17 1.9k
Jean‐Michel Bruneau France 15 251 0.3× 602 0.9× 190 0.3× 217 0.4× 204 0.7× 19 1.3k
Deborah R. Wysong United States 15 412 0.4× 912 1.4× 259 0.5× 273 0.5× 98 0.3× 19 1.7k
Erika Shor United States 19 570 0.6× 681 1.1× 474 0.9× 192 0.4× 71 0.2× 32 1.3k
Paul L. Skatrud United States 23 498 0.5× 1.6k 2.5× 209 0.4× 361 0.7× 775 2.6× 45 2.6k
Tsuyoshi Yamada Japan 22 321 0.3× 657 1.0× 931 1.7× 195 0.4× 187 0.6× 88 1.8k
R. Datema Germany 29 470 0.5× 1.3k 2.0× 633 1.2× 186 0.4× 68 0.2× 76 2.5k
Benjamin P. Thornton United States 7 183 0.2× 270 0.4× 118 0.2× 287 0.6× 133 0.5× 9 1.2k
František Supek United States 20 75 0.1× 867 1.4× 380 0.7× 268 0.5× 34 0.1× 25 1.7k
Fernanda Canduri Brazil 28 253 0.3× 1.2k 1.8× 234 0.4× 61 0.1× 96 0.3× 66 1.6k
Fazal Shirazi United States 19 251 0.3× 421 0.7× 132 0.2× 70 0.1× 65 0.2× 36 1.1k

Countries citing papers authored by J A Marrinan

Since Specialization
Citations

This map shows the geographic impact of J A Marrinan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Marrinan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Marrinan more than expected).

Fields of papers citing papers by J A Marrinan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Marrinan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Marrinan. The network helps show where J A Marrinan may publish in the future.

Co-authorship network of co-authors of J A Marrinan

This figure shows the co-authorship network connecting the top 25 collaborators of J A Marrinan. A scholar is included among the top collaborators of J A Marrinan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Marrinan. J A Marrinan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Douglas, Cameron, M. Meinz, Janet C. Onishi, et al.. (1997). Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrobial Agents and Chemotherapy. 41(11). 2471–2479. 262 indexed citations
2.
Zambias, Robert A., Catherine E. James, George K. Abruzzo, et al.. (1997). Lipopeptide antifungal agents: Amine conjugates of the semi-synthetic pneumocandins L-731,373 and L-733,560. Bioorganic & Medicinal Chemistry Letters. 7(15). 2021–2026. 4 indexed citations
3.
Kurtz, Martha, George K. Abruzzo, Amy Flattery, et al.. (1996). Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infection and Immunity. 64(8). 3244–3251. 110 indexed citations
4.
Kurtz, Martha, E M Bernard, F F Edwards, et al.. (1995). Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 39(8). 1784–1789. 44 indexed citations
5.
Zambias, Robert A., Catherine E. James, Milton L. Hammond, et al.. (1995). Antifungal lipopeptides: Structure-activity relationships of 3-hydroxyglutamine-modified pneumocandin B0 derivatives. Bioorganic & Medicinal Chemistry Letters. 5(20). 2357–2362. 4 indexed citations
6.
Bouffard, F. Aileen, Robert A. Zambias, James F. Dropinski, et al.. (1994). Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives. Journal of Medicinal Chemistry. 37(2). 222–225. 94 indexed citations
7.
Bouffard, F. Aileen, Robert A. Zambias, James F. Dropinski, et al.. (1994). ChemInform Abstract: Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives.. ChemInform. 25(20). 17 indexed citations
8.
Douglas, Cameron, F Foor, J A Marrinan, et al.. (1994). The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase.. Proceedings of the National Academy of Sciences. 91(26). 12907–12911. 335 indexed citations
9.
Kurtz, Martha, Cameron Douglas, J A Marrinan, et al.. (1994). Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrobial Agents and Chemotherapy. 38(12). 2750–2757. 60 indexed citations
10.
Kurtz, Martha, I. Brent Heath, J A Marrinan, et al.. (1994). Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrobial Agents and Chemotherapy. 38(7). 1480–1489. 273 indexed citations
11.
Douglas, Cameron, et al.. (1994). A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase. Journal of Bacteriology. 176(18). 5686–5696. 103 indexed citations
12.
Horn, Wendy S., Jack L. Smith, Gerald F. Bills, et al.. (1992). Sphingofungins F and F: Novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii.. The Journal of Antibiotics. 45(10). 1692–1696. 108 indexed citations
13.
Lott, T. J., P. T. Magee, Richard Barton, et al.. (1992). The molecular genetics ofCandida albicans. Medical Mycology. 30(s1). 77–85. 5 indexed citations
14.
Monk, Brian C., Martha Kurtz, J A Marrinan, & David S. Perlin. (1991). Cloning and characterization of the plasma membrane H(+)-ATPase from Candida albicans. Journal of Bacteriology. 173(21). 6826–6836. 94 indexed citations
15.
Kurtz, Myra B. & J A Marrinan. (1989). Isolation of Hem3 mutants from Candida albicans by sequential gene disruption. Molecular and General Genetics MGG. 217(1). 47–52. 35 indexed citations
16.
Bock, Susan, J A Marrinan, & Elzbieta Radziejewska. (1988). Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site. Biochemistry. 27(16). 6171–6178. 65 indexed citations
17.
Bock, Susan, Karen Skriver, Virginia H. Donaldson, et al.. (1986). Human C.hivin.1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry. 25(15). 4292–4301. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Michel Bruneau Breakdown of academic impact, for papers by Deborah R. Wysong Breakdown of academic impact, for papers by Erika Shor Breakdown of academic impact, for papers by Paul L. Skatrud Breakdown of academic impact, for papers by Tsuyoshi Yamada Breakdown of academic impact, for papers by R. Datema Breakdown of academic impact, for papers by Benjamin P. Thornton Breakdown of academic impact, for papers by František Supek Breakdown of academic impact, for papers by Fernanda Canduri Breakdown of academic impact, for papers by Fazal Shirazi
Rankless by CCL
2026